Literature DB >> 25952737

¹⁸F-NaF Uptake by Atherosclerotic Plaque on PET/CT Imaging: Inverse Correlation Between Calcification Density and Mineral Metabolic Activity.

Francesco Fiz1, Silvia Morbelli2, Arnoldo Piccardo3, Matteo Bauckneht2, Giulia Ferrarazzo2, Emanuela Pestarino3, Manlio Cabria3, Alessia Democrito2, Mattia Riondato4, Giampiero Villavecchia3, Cecilia Marini5, Gianmario Sambuceti2.   

Abstract

UNLABELLED: Several studies have highlighted the role of vascular (18)F-NaF uptake as a marker of ongoing calcium deposition. However, accumulation of (18)F-NaF is often inconsistent with localization of arterial plaque. Calcification activity and thus (18)F-NaF uptake might prevail in the earlier plaque stages. To test this hypothesis, we evaluated (18)F-NaF uptake in plaque of 3 different densities, using density as a marker of calcification progression. We also tested whether attenuation-weighted image reconstruction affects (18)F-NaF uptake in the different plaque stages.
METHODS: Sixty-four oncologic patients (14 men and 50 women; mean age, 65.3 ± 8.2 y; range, 26-81 y) underwent (18)F-NaF PET/CT. A volume of interest was drawn on each plaque within the infrarenal aorta to assess mean standardized uptake value and attenuation (in Hounsfield units [HU]). Plaque was then categorized as light (<210 HU), medium (211-510 HU), or heavy (>510 HU). Standardized uptake value was normalized for blood (18)F-NaF activity to obtain the plaque target-to-background ratio (TBR). During this process, several focal, noncalcified areas of (18)F-NaF were identified (hot spots). The TBR of the hot spots was computed after isocontour thresholding. The TBR of a noncalcified control region was also calculated. In 35 patients, the TBR of non-attenuation-corrected images was calculated.
RESULTS: The average TBR was highest in light plaque (2.21 ± 0.88), significantly lower in medium plaque (1.59 ± 0.63, P < 0.001), and lower still in heavy plaque (1.14 ± 0.37, P < 0.0001 with respect to both light and medium plaque). The TBR of the control region was not significantly different from that of heavy plaque but was significantly lower than that of light and medium plaque (P < 0.01). Hot spots had the highest absolute TBR (3.89 ± 1.87, P < 0.0001 vs. light plaque). TBRs originating from non-attenuation-corrected images did not significantly differ from those originating from attenuation-corrected images.
CONCLUSION: Our results support the concept that (18)F-NaF is a feasible option in imaging molecular calcium deposition in the early stages of plaque formation, when active uptake mechanisms are the main determinants of calcium presence, but that retention of (18)F-NaF progressively decreases with increasing calcium deposition in the arterial wall. Our data suggest that non-attenuation-corrected reconstruction does not significantly affect evaluation of plaque of any thickness.
© 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  18F-natrium fluoride; PET/CT; plaque imaging

Mesh:

Substances:

Year:  2015        PMID: 25952737     DOI: 10.2967/jnumed.115.154229

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  25 in total

1.  From inflammation to calcification in atherosclerosis.

Authors:  Takehiro Nakahara; H William Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-05       Impact factor: 9.236

2.  Metabolic and densitometric correlation between atherosclerotic plaque and trabecular bone: an 18F-Natrium-Fluoride PET/CT study.

Authors:  Francesco Fiz; Matteo Bauckneht; Arnoldo Piccardo; Cristina Campi; Alberto Nieri; Roberta Piva; Giulia Ferrarazzo; Nathan Artom; Silvia Morbelli; Cecilia Marini; Michele Piana; Marcello Bagnasco; Marco Canepa; Gianmario Sambuceti
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-12-20

3.  Two-year change in 18F-sodium fluoride uptake in major arteries of healthy subjects and angina pectoris patients.

Authors:  Reza Piri; Gauher Lici; Pooriya Riyahimanesh; Oke Gerke; Abass Alavi; Poul Flemming Høilund-Carlsen
Journal:  Int J Cardiovasc Imaging       Date:  2021-05-05       Impact factor: 2.357

Review 4.  Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with (18)F positron emission tomography.

Authors:  Daniel J Scherer; Peter J Psaltis
Journal:  Cardiovasc Diagn Ther       Date:  2016-08

5.  Effects of teriparatide on morphology of aortic calcification in aged hyperlipidemic mice.

Authors:  Jeffrey J Hsu; Jinxiu Lu; Soban Umar; Jason T Lee; Rajan P Kulkarni; Yichen Ding; Chih-Chiang Chang; Tzung K Hsiai; Akishige Hokugo; Ioannis Gkouveris; Sotirios Tetradis; Ichiro Nishimura; Linda L Demer; Yin Tintut
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-02-16       Impact factor: 4.733

6.  Quantitative thoracic aorta calcification assessment by 18F-NaF PET/CT and its correlation with atherosclerotic cardiovascular disorders and increasing age.

Authors:  Koosha Paydary; Mona-Elisabeth Revheim; Sahra Emamzadehfard; Saeid Gholami; Sara Pourhassan; Thomas J Werner; Poul Flemming Høilund-Carlsen; Abass Alavi
Journal:  Eur Radiol       Date:  2020-09-01       Impact factor: 5.315

Review 7.  Recent Advances in Nuclear Cardiology.

Authors:  Won Woo Lee
Journal:  Nucl Med Mol Imaging       Date:  2016-07-13

8.  Molecular Imaging of Atherosclerosis: A Clinical Focus.

Authors:  Mohammed M Chowdhury; Ahmed Tawakol; Farouc A Jaffer
Journal:  Curr Cardiovasc Imaging Rep       Date:  2017-02-04

9.  Correlation between thoracic aorta 18F-natrium fluoride uptake and cardiovascular risk.

Authors:  Francesco Fiz; Silvia Morbelli; Matteo Bauckneht; Arnoldo Piccardo; Giulia Ferrarazzo; Alberto Nieri; Nathan Artom; Manlio Cabria; Cecilia Marini; Marco Canepa; Gianmario Sambuceti
Journal:  World J Radiol       Date:  2016-01-28

10.  Performance Evaluation of a Dedicated Preclinical PET/CT System for the Assessment of Mineralization Process in a Mouse Model of Atherosclerosis.

Authors:  Guillaume Rucher; Lucie Cameliere; Jihene Fendri; Ahmed Abbas; Kevin Dupont; Said Kamel; Nicolas Delcroix; Axel Dupont; Ludovic Berger; Alain Manrique
Journal:  Mol Imaging Biol       Date:  2018-12       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.